Array

UNESP
AUIN | Agência Unesp de Inovação
   

Tecnology

NANOSTRUCTURED SYSTEM FOR PBMICOSE TREATMENT 

Carimbo Unesp

Attractive

Prevents injury to patients

Effective treatment
Human Health
PROBLEM

PCM is a disease of great importance for Latin America due to its frequency, severity of some forms and mortality rates. The human infection occurs mainly through the respiratory system by the inhalation of the infecting form of the fungus Paracoccidiodes brasiliensis.

 

Treatment for PCM includes antibiotics and chemotherapeutics of synthetic origin, with Amphotericin B being the most commonly used antifungal. However, its toxicity causes problems for the kidneys and can also cause anemia by acting directly on the bone marrow. This new technology presents itself as a new approach in the treatment of PCM without presenting the problems existing by the current treatments.

SOLUTION

This new technology is showed as an excellent antifungal substance, without toxicity and with a high index of selectivity, 30 times bigger and safer than the drugs currently used in the treatment of PCM.


Idea

Laboratory

Prototype

Scheduling

Market
Agency Code
14AUIN006
Patent
BR102015004661-8

Agência Unesp de Inovação

Tel: +55 11 5627.0696

auin@unesp.br

https://auin.unesp.br

Facebook AUIN Unesp Youtube AUIN Unesp Instagram AUIN Unesp